Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report

In an immune-competent context nivolumab showed long-term benefit in overall survival in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC); however, in special cancer population such as these patients with immunodeficiency and viral infections, data on checkpoint inhibitors (ICI) ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Locati, Laura Deborah, Serafini, Mara Serena, Carenzo, Andrea, Canevari, Silvana, Perrone, Federica, Orlandi, Ester, Delbue, Serena, Cavalieri, Stefano, Berzeri, Giulia, Pichiecchio, Anna, Licitra, Lisa Francesca, Marchioni, Enrico, De Cecco, Loris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784387/
https://www.ncbi.nlm.nih.gov/pubmed/35083153
http://dx.doi.org/10.3389/fonc.2021.799453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784387/
https://www.ncbi.nlm.nih.gov/pubmed/35083153
http://dx.doi.org/10.3389/fonc.2021.799453

Ejemplares similares